D. E. Shaw & Co., Inc. Harrow Health, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 468,188 shares of HROW stock, worth $12.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
468,188
Previous 664,714
29.57%
Holding current value
$12.3 Million
Previous $22.3 Million
44.16%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$104 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$56.6 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$49.8 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$49.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$25.2 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $713M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...